MDM2 and p53 expression in gliomas: A multivariate survival analysis including proliferation markers and epidermal growth factor receptor

British Journal of Cancer

Volumn 75, Issue 9, 1997, Pages 1269-1278

  Korkolopoulou, P ^a,b   Christodoulou, P ^a   Kouzelis, K ^a   Hadjiyannakis, M ^a   Priftis, A ^a   Stamoulis, G ^a   Seretis, A ^a   Thomas Tsagli, E ^a  

^a Asklepeion Hospital   (Greece)

^b NONE   (Greece)

Author keywords

AgNORs; Epidermal growth factor receptor; Gliomas; Ki 67; MDM2; MIB 1; p53; Proliferating cell nuclear antigen

Indexed keywords

CYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR; ONCOPROTEIN; PROTEIN P53;

ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER SURVIVAL; FEMALE; GLIOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OLIGODENDROGLIOMA; PRIORITY JOURNAL;

EID: 0030970202     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.216     Document Type: Article

References (53)

1. Allegranza A, Girlando S, Arrigoni GL, Veronese S, Mauri PA, Gambacorta M, Pollo B, Dalla Palma P and Barbareschi M (1991) Proliferating cell nuclear antigen expression in central nervous system neoplasms. Virchows Arch (A) 419: 417-423
2. Barbareschi M, Inzzolino P, Pennella A, Allegranza A, Arrigoni G, Dalla Palma P and Doglioni C (1992) p53 protein expression in central nervous system neoplasms. J Clin Pathol 45: 583-586
3. Barbareschi M, Girlando S, Fellin G, Graffer U, Luciani L and Dalla Palma P (1995) Expression of mdm-2 and p53 protein in transitional cell carcinoma. Urol Res 22: 349-352
4. Bigner SH and Vogelstein B (1990) Cytogenetics and molecular genetics of malignant gliomas and medulloblastomas. Brain Pathol 1: 12-17
5. Burger PC, Shibata T and Kleihues P (1986) The use of monoclonal antibody Ki-67 in the identification of proliferating cells. Application to neuropathology. Am J Surg Pathol 57: 269-276
6. Cordon-Cardo C, Latres E, Drobnjak M, Oliva MR, Pollack D, Woodruff JM, Marechal V, Chen JD, Brennan MF and Levine AJ (1994) Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res 54: 794-799
7. Cox DR (1972) Regression models and life tables. J Roy Stat B 34: 187-220
8. Diedrich V, Lucius J, Baron E, Bejnke J, Pabst B and Zoll B (1995) Distribution of epidermal growth factor receptor gene amplification in brain tumours and correlation to prognosis. J Neurol 242: 683-688
9. Figge C, Reifenberger G, Vogeley KT, Messing M, Roosen N and Wechsler W (1992) Immunohistochemical demonstration of proliferating cell nuclear antigen in glioblastomas: pronounced heterogeneity and lack of prognostic significance. J Cancer Res Clin Oncol 118: 289-295
10. Finlay CA, Hinds PW and Levine AJ (1989) The p53 protooncogene can act as a suppressor of transformation. Cell 57: 1083-1093
11. Haapasalo H, Isola J, Sallinen P, Kalimo H, Helin H and Rantala I (1993) Aberrant p53 expression in astrocytic neoplasms of the brain: association with proliferation. Am J Pathol 142: 1347-1351
12. Hunter T (1984) The epidermal growth factor receptor gene and its product. Nature 311: 414-416
13. Iggo R, Gatter K, Bartek J, Lane D and Harris AL (1990) Increased expression of mutant forms of p53 oncogen in primary lung cancer. Lancet 335: 675-679
14. Jaros E, Perry RH, Adam L, Kelly PJ, Crawford PJ, Kalbag RM, Mendelew AD, Sengupta RP and Pearson ADJ (1992) Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours. Br J Cancer 66: 373-385
15. Kajiwara K, Nishizaki T, Orita T, Nakayama H, Aoki H and Ito H (1990) Silver colloid staining technique for analysis of glioma malignancy. J Neurosurg 73: 113-117
16. Karamitopoulou E, Perentes E, Melachrinou M and Maraziotis T (1993) Proliferating cell nuclear antigen immunoreactivity in human central nervous system neoplasms. Acta Neuropathol 85: 316-322
17. Karamitopoulou E, Perentes E, Diamantis I and Maraziotis T (1994) Ki-67 immunoreactivity in human central nervous system tumours: a study with MIB1 monoclonal antibody on archival material. Acta Neuropathol 87: 47-54
18. Karkaravelas G, Mavropoulou S, Fountzilas G, Christoforidou V, Karavelis A, Foroglou G and Papadimitriou K (1995) Correlation of proliferating cell nuclear antigen assessment, histologic parameters and age with survival in patients with glioblastoma multiforme. Anticancer Res 15: 531-536
19. Kleihues P, Burger PC and Scheithauer BW (1993) The new WHO classification of brain tumours. Brain Pathol 3: 255-268
20. Korkolopoulou P, Christodoulou P, Papanikolaou A and Thomas-Tsagli E (1993) Proliferating cell nuclear antigen (PCNA) and nucleolar organizer regions (NORs) in CNS tumours. Correlation with histologic type and grade. Am J Surg Pathol 17: 912-919
21. Korkolopoulou P, Christodoulou P, Lekka-Katsouli I, Kouzelis K, Papanikolaou A, Panayotides I, Mariatos P, Thomas-Tsagli E and Crocker J (1994) Prognostic significance of proliferating cell nuclear antigen (PCNA) expression in gliomas. Histopathology 25: 349-355
22. Kyritsis AP, Xu R, Bondy ML, Levin VA and Bruner JM (1996) Correlation of p53 immunoreactivity and sequencing in patients with glioma. Mol Carcinog 15: 1-4
23. Lane DP (1992) p53, guardian of the genome. Nature 358: 15-16
24. Libermann TA, Razon N, Bartal AD, Yarden Y, Schlessiger J and Soreq H (1984) Expression of epidermal growth factor receptors in human brain tumours. Cancer Res 44: 753-760
25. Louis DN (1994) The p53 gene and protein in human brain tumours. J Neuropathol Exp Neurol 53: 11-21
26. Louis DN, Edgerton S, Thor AD and Hedley-White ET (1991) Proliferating cell nuclear antigen and Ki-67 immunohistochemistry in brain tumours: a comparative study. Acta Neuropathol 81: 675-679
27. Louis DN, Von Deimling A, Chung RY, Rubio MP, Whaley JM, Eibl RH, Ohgaki H, Wiestler OD, Thor AD and Seizinger BR (1993) Comparative study of p53 gene and protein alterations in human astrocytic tumors. J Neuropathol Exp Neurol 52: 31-38
28. Maestro R, Dolcetti R, Gasparotto D, Doglioni C, Pelucchi S, Barzan L, Grandi E and Boiocchi M (1992) High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Oncogene 7: 1159-1166
29. Maier H, Morimura T, Öfner D, Hallbrucker C, Kitz K and Budka H (1990) Argyrophilic nucleolar organizer region proteins (AgNORs) in human brain tumours: relations with grade of malignancy and proliferation indices. Acta Neuropathol 80: 156-162
30. Meltzer PS (1994) MDM-2 and p53: a question of balance. J Natl Cancer Inst 86: 1265-1266
31. Mercer WE, Shields MT, Lin D, Appela E and Ullrich SJ (1991) Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating cell nuclear antigen expression. Proc Natl Acad Sci USA 88: 1958-1962
32. Momand J, Zambett GP, Olson DC, George DL and Levine AJ (1992) The MDM-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69 1237-1245
33. Newcomb EW, Madonia WJ, Pisharody S, Lang FF, Koslow M and Miller DC (1993) A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme. Brain Pathol 3: 229-235
34. Nicoll JA and Candy E (1991) Nucleolar organizer regions and postoperative survival in glioblastoma multiforme. Neuropathol Appl Neurobiol 17: 17-20
35. Norton AJ, Jordan S and Yeomans P (1994) Brief, high-temperature heat denaturation (pressure cooking): a simple and effective method of antigen retrieval for routinely processed tissues. J Pathol 173: 371-379
36. Ohgaki H, Eibl RH, Wiestler OD, Yasargil MG, Newcomb EW and Kleihues P (1991) p53 mutations in non-astrocytic human brain tumours. Cancer Res 51: 6202-6205
37. Pignatelli M, Stamp GVH, Kafiri G, Lane D and Bodimer WF (1992) Overexpression of p53 nuclear oncoprotein in colorectal adenomas. Int J Cancer 50: 683-688
38. Plate KH, Rueschoff J, Behnke J and Mennel HD (1990) Proliferative potential of human brain tumours as assessed by nucleolar organizer regions (AgNORs) and Ki-67 immunoreactivity. Acta Neurochir (Wien) 104: 103-109
39. Rasheed ABK, McLendon RE, Herndon JE, Friedman HS, Friedman AH, Bigner DD and Bigner SH (1994) Alterations of the TP53 gene in human gliomas. Cancer Res 54: 1324-1330
40. Reich NC and Levine AJ (1984) Growth regulation of a cellular tumour antigen p53, in non-transformed cells. Nature 308: 199-201
41. Reifenberger G, Prior R, Deckert M and Wechsler W (1989) Epidermal growth factor receptor expression and growth fraction in human tumours of the nervous system. Virchows Arch (A) 414: 147-155
42. Reifenberger G, Liu L, Ichimura K, Schmidt E and Collins V (1993) Amplification and overexpression of MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res 53: 2736-2739
43. Rubio MP, Deimling A, Ynadell DW, Wiestler OD, Gusella JF and Louis DN (1993) Accumulation of wild type p53 protein in human astrocytomas. Cancer Res 53: 3465-3467
44. Russel DS and Rubinstein LJ (1989) Tumours of central neuroepithelial origin. In Pathology of Tumours of the Nervous System. Russel DS and Rubinstein LJ (eds), pp. 83-350. Edward Arnold: London
45. Sallinen P, Haapasalo H, Visakorpi T, Helen PT, Rantala IS, Isola JJ and Helin HJ (1994) Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin embedded samples. J Pathol 174: 275-282
46. Schröder R, Bien K, Kott R, Meyers I and Vössing R (1991) The relationship between Ki-67 labelling and mitotic index in gliomas and meningiomas: demonstration of the variability of the intermitotic cycle time. Acta Neuropathol 82: 389-394
47. Soini Y, Niemela A, Kamel D, Herva R, Bloigu R, Pääkkö P and Vähäkangas K (1994) p53 immunohistochemical positivity as a prognostic marker in intracranial tumours. APMIS 102: 786-792
48. Theunissen PHMH and Blaauw G (1993) Proliferating cell nuclear antigen immunostaining and survival in cerebral astrocytoma. Histopathology 23: 75-79
49. Van Meyel DJ, Ramsay DA, Casson AG, Keeney M, Chambers AF and Cairncross G (1994) p53 mutation, expression and DNA ploidy in evolving gliomas: evidence for two pathways of progression. J Natl Cancer Inst 86: 1011-1017
50. Vigliani CM, Chiò A, Pezzulo T, Soffietti R, Giordana MT and Schiffer D (1994) Proliferating cell nuclear antigen (PCNA) in low-grade astrocytomas: its prognostic significance. Tumori 80: 295-300
51. Xiao ZX, Chen J, Levine AJ, Modjtahedi N, Xing J, Sellers WR and Livingston DM (1995) Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 375: 694-698
52. Zhu A, Shaeffer J, Leslie S, Kolm P and El-Mahdi AM (1996) Epidermal growth factor receptor: an independent predictor of survival in astrocytic tumors given definitive irradiation. Int J Radiat Oncol Biol Phys 34: 809-815
53. Zuber P, Hamou M-F and De Tribolet N (1988) Identification of proliferating cells in human gliomas using the monoclonal antibody Ki-67. Neurosurgery 22: 364-368